Glycopyrrolate Tablet
Product Images NDC 0615-8617

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Glycopyrrolate (NDC 0615-8617). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ncs Healthcare Of Ky, Llc Dba Vangard Labs, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Glycopyrrolate Tabs 8617 1)

Chemical structure of glycopyrrolate showing its molecular configuration including a quaternary ammonium group with bromide ion.*

FDA Label Image

Principal Display Panel (Glycopyrrolate Tabs 8617 2)

Label for Glycopyrrolate Tablets USP 1 mg, intended for oral use. The label indicates a quantity of 30 tablets, manufactured by Aurobindo and packaged by Vangard in Glasgow, KY. Includes multiple small barcode labels, directions for storage at controlled room temperature, and a section for institutional use only. The label prominently features the product name, strength, lot number, and manufacturer details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.